Covid Newscast

The Next-Generation Of Scientific Exploration And Research

Skip to content
  • Categories
    • Discovery
    • Clinical
    • Clinical Trials
    • Long Covid
    • Vaccines
    • Computing
    • Pandemic
    • Antibodies
  • Analytics
  • Resources
  • About Ingentium

Clinical Trials

Information on Covid-19 clinical trials

  • Literature

  • Media

  • News

  • Clinical Trials Literature

    A Practical Review of Adaptive Platform Trials.

    December 2, 2025
    Publication date: Nov 19, 2025Traditional randomized controlled trials (RCTs) can provide rigorous evidence but are ...
  • Clinical Trials Literature

    Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.

    December 1, 2025
    Publication date: Nov 29, 2025Type 1 diabetes begins with autoimmunity against pancreatic islet antigens, including ...
  • Clinical Trials Literature

    “If I am here, it is because the system failed”: a critical qualitative study of global commercial clinical trials for advanced cancer in Chile.

    December 1, 2025
    Publication date: Nov 28, 2025The pharmaceutical industry is a key global health actor given its ...
  • Clinical Trials Literature

    Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants’ experiences in a pilot clinical trial.

    December 1, 2025December 1, 2025
    Publication date: Nov 28, 2025Commonly known as “long COVID”, post-acute sequelae of COVID-19 (PASC) is ...
  • Clinical Trials Literature

    Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial.

    November 30, 2025
    Publication date: Nov 11, 2025Background: Numerous studies have proved the efficacy of vaccination in reducing ...
  • Clinical Trials Literature

    Digital Storytelling to Reduce Hispanic Parents’ COVID-19 Vaccine Hesitancy: A Pilot Randomized Controlled Trial.

    November 30, 2025
    Publication date: Oct 24, 2025Hispanic children in the U. S. experience disproportionately low COVID-19 vaccination ...
  • Clinical Trials Literature

    Efficacy of the Web-Based Gamified Infection Control Training System on Practices for Health Care Workers in Residential Care Homes: Clustered Randomized Controlled Trial.

    November 30, 2025
    Publication date: Nov 27, 2025Staff working in residential care homes (RCHs) have played a significant ...
  • Clinical Trials Literature

    Effect of Motion-Controlled Video Games-Based Virtual Reality Exercise on Patients with Post-COVID-19 Condition: A Randomized Controlled Trial.

    November 30, 2025November 30, 2025
    Publication date: Nov 14, 2025Objective: Virtual reality (VR) exercises may offer a comprehensive rehabilitation approach ...
  • Clinical Trials Literature

    Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study.

    November 30, 2025
    Publication date: Dec 01, 2025Checkpoint inhibitors, including combinations with standard-of-care chemotherapy, have shown survival benefit ...
  • Clinical Trials Literature

    SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

    November 30, 2025
    Publication date: Dec 01, 2025Standardising the implementation of patient-reported outcomes (PROs) in clinical trials is ...
  • Clinical Trials Literature

    Phase 1 Randomized Controlled Trial of the Safety and Immunogenicity of the SARS-CoV-2 (Omicron BA.5) mRNA-CR-04 Vaccine in Adults 18-49 Years of Age.

    November 30, 2025
    Publication date: Dec 01, 2025This study (NCT05972993) evaluated a novel mRNA vaccine construct using the ...
  • Clinical Trials Literature

    Antiviral clinical trial design throughout the COVID pandemic: evolving endpoints and lessons learnt.

    November 30, 2025
    Publication date: Nov 28, 2025Trial design during the novel coronavirus-19 (COVID-19) pandemic was stymied by ...
  • Clinical Trials Literature

    Profile of clinical trials with drugs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Spain.

    November 30, 2025
    Publication date: Nov 27, 2025On 11 March 2020, World Health Organisation declared COVID-19 a pandemic. ...
  • Clinical Trials Literature

    Incidence of stroke following COVID-19 vaccination: a nationwide self-controlled risk interval study in Qatar.

    November 28, 2025
    Publication date: Nov 26, 2025This study assessed short-term stroke risk following COVID-19 vaccination using Qatar’s ...
  • Clinical Trials Literature

    Identifying Barriers and Motivators to Increase Surgical Clinical Trial Participation for Older Veterans.

    November 28, 2025
    Publication date: Nov 26, 2025Patients aged 65+ are underrepresented in surgical clinical trials, and few ...
  • Clinical Trials Literature

    Workplace stressors and burnout among healthcare professionals: Insights from the pandemic and implications for future public health crises.

    November 28, 2025
    Publication date: Nov 26, 2025This study evaluates the prevalence of burnout among healthcare professionals (HCPs) ...
  • Clinical Trials Literature

    ‘Lessons learned’ from trialists who adapted a complex intervention for remote delivery within a trial as a result of the COVID-19 pandemic: a scoping review.

    November 27, 2025
    Publication date: Nov 25, 2025During the COVID-19 pandemic, complex interventions being evaluated in randomised controlled ...
  • Clinical Trials Literature

    One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in Thailand.

    November 27, 2025
    Publication date: Nov 25, 2025To promote self-reliance in vaccine production, a chimeric Newcastle Disease Virus ...
  • Clinical Trials Literature

    Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials.

    November 27, 2025
    Publication date: Nov 25, 2025BACKGROUND AND OBJECTIVE: The evidence on molnupiravir for the treatment of ...
  • Clinical Trials Literature

    Simulation-Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies.

    November 27, 2025
    Publication date: Oct 07, 2025Bayesian predictive probabilities of success (PPoS) use interim trial data to ...
  • Clinical Trials Literature

    Using a mental model approach to undercut the effects of exposure to mRNA vaccination misconceptions: Two randomized trials.

    November 26, 2025
    Publication date: Dec 02, 2025Although messenger RNA (mRNA) technology revolutionized vaccine creation, its use is ...

Posts navigation

Older posts
ingentium

Ingentium Inc.
Email: support@ingentium.com
© 2016-2025 Ingentium, Inc.

Additional

  • Analytics
  • Contact Us
  • Terms of Service Agreement

Archives

  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}